التداول ينطوي على مخاطر
الاستثمارات تنطوي على مخاطر وليست مناسبة لجميع المستثمرين. العقود مقابل الفروقات هي أدوات معقدة وتنطوي على مخاطر عالية لخسارة الأموال بسرعة بسبب الرافعة المالية.
التداول ينطوي على مخاطر
الاستثمارات تنطوي على مخاطر وليست مناسبة لجميع المستثمرين. العقود مقابل الفروقات هي أدوات معقدة وتنطوي على مخاطر عالية لخسارة الأموال بسرعة بسبب الرافعة المالية.
ResMed Inc
Closed
Sector Healthcare
248.13 -0.08
Overview
Share price change
24h
Min
245.32
Max
252.14
Income | 19M 311M |
|---|---|
Sales | 1.2B |
P/E Sector Avg | 35.28 94.998 |
EPS | 2.2 |
Dividend yield | 0.9 |
Profit margin | 25.521 |
EBITDA | 79M 441M |
Recommendations | Buy |
|---|---|
12 Months Forecast | -0.88 downside |
Dividend yield Sector Avg | 0.90% 2.40% |
|---|---|
Next Earnings | ٢٢ يناير ٢٠٢٥ |
Next Dividend date | ١٢ ديسمبر ٢٠٢٤ |
Next Ex Dividend date | ٥ فبراير ٢٠٢٥ |
Market Cap | -2.1B 34B |
|---|---|
Previous open | 248.21 |
Previous close | 248.13 |
News Sentiment
By Acuity
17%
83%
34 / 392 Ranking in Healthcare
Technical Score
By Trading Central
Confidence
Bullish Evidence
ResMed Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
ResMed Inc Forecast
Price Target
By TipRanks
-0.88% downside
12 Months Forecast
Average 247.14 USD -0.88%
High 283 USD
Low 180 USD
Based on 10 Wall Street analysts offering 12 month price targets forResMed Inc - Dist in the last 3 months.
Sentiment
By Acuity
34 / 392 Ranking in Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About ResMed Inc
ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.
